GTS Internasional Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? GTS Internasional Tbk. trades at Rp134 (market cap 2.2T, 19.55M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B, 71K 24h volume). The key difference: GTS Internasional Tbk. is far larger — about 13.1× Brigit Biofarmaka Teknologi Tbk.'s market cap, and GTS Internasional Tbk. is more actively traded (19.55M versus 71K). Which is the better fit depends on your goals.
| GTSI | OBAT | |
|---|---|---|
Market Cap | 2.2T | 167.37B |
Volume | 19.55M | 71K |
Lot | 195.46K | 710 |
Turnover | 2.63B | 17.51M |
Average Price | 134.62 | 246.63 |
Value | 2.63B | 17.51M |
Indicative Equilibrium Price | 134 | 246 |
Indicative Equilibrium Volume | 7.31K | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT GTS Internasional Tbk (the “Company”) was established based on Notarial Deed No. 32 dated June 29, 2012 of Martina, S.H. The Company started its commercial operations in August 2019. The Company’s parent entity is PT Hateka Trans Internasional and ultimate parent entity is PT Humpuss Intermoda Transportasi Tbk.
Read more on GTSI →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →